메뉴 건너뛰기




Volumn 24, Issue 8, 2013, Pages 800-806

Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation

(308)  Marcucci, Maura a,b,h,t   Nobili, Alessandro c   Tettamanti, Mauro c,h   Iorioa, Alfonso a,b,t   Pasina, Luca c   Djade, Codjo D c,h   Franchi, Carlotta c   Marengoni, Alessandra d,j   Salerno, Francesco e,i   Corrao, Salvatore f   Violi, Francesco g,bk   Mannucci, Pier Mannuccio h   Sparacio, Eleonora h   Alborghetti, Stefania h   Di Costanzo, Rosa h   Prisco, Domenico k   Silvestri, Elena k   Cenci, Caterina k   Barnini, Tommaso k   Delitala, Giuseppe l   more..


Author keywords

Atrial fibrillation; Bleeding risk; Cardioembolic risk; Elderly; Prediction guides; Thromboprophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

EID: 84889635221     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.08.697     Document Type: Article
Times cited : (13)

References (27)
  • 1
    • 0035851288 scopus 로고    scopus 로고
    • Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting
    • D. McCormick, J.H. Gurwitz, R.J. Goldberg, R. Becker, J.P. Tate, and A. Elwell Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting Arch Intern Med 161 2001 2458 2463
    • (2001) Arch Intern Med , vol.161 , pp. 2458-2463
    • McCormick, D.1    Gurwitz, J.H.2    Goldberg, R.J.3    Becker, R.4    Tate, J.P.5    Elwell, A.6
  • 2
    • 27444435844 scopus 로고    scopus 로고
    • NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation
    • A.L. Waldo, R.C. Becker, V.F. Tapson, and K.J. Colgan NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation J Am Coll Cardiol 46 2005 1729 1736
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1729-1736
    • Waldo, A.L.1    Becker, R.C.2    Tapson, V.F.3    Colgan, K.J.4
  • 3
    • 78649508381 scopus 로고    scopus 로고
    • Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards
    • M. Marcucci, A. Iorio, A. Nobili, M. Tettamanti, L. Pasina, and A. Marengoni Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards Eur J Intern Med 21 2010 516 523
    • (2010) Eur J Intern Med , vol.21 , pp. 516-523
    • Marcucci, M.1    Iorio, A.2    Nobili, A.3    Tettamanti, M.4    Pasina, L.5    Marengoni, A.6
  • 4
    • 73849098278 scopus 로고    scopus 로고
    • Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: A prospective, descriptive study
    • L.R. Tulner, J.P. van Campen, I.M. Kuper, G.J. Gijsen, C.H. Koks, and M.R. Mac Gillavry Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study Drugs Aging 27 2010 39 50
    • (2010) Drugs Aging , vol.27 , pp. 39-50
    • Tulner, L.R.1    Van Campen, J.P.2    Kuper, I.M.3    Gijsen, G.J.4    Koks, C.H.5    Mac Gillavry, M.R.6
  • 5
    • 84871750425 scopus 로고    scopus 로고
    • Thromboprophylaxis of elderly patients with AF in the UK: An analysis using the General Practice Research Database (GPRD) 2000-2009
    • A.C. Scowcroft, S. Lee, and J. Mant Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009 Heart 99 2013 127 132
    • (2013) Heart , vol.99 , pp. 127-132
    • Scowcroft, A.C.1    Lee, S.2    Mant, J.3
  • 6
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 7
    • 84860483079 scopus 로고    scopus 로고
    • The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: A nationwide cohort study
    • J.B. Olesen, C. Torp-Pedersen, M.L. Hansen, and G.Y. Lip The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study Thromb Haemost 107 2012 1172 1179
    • (2012) Thromb Haemost , vol.107 , pp. 1172-1179
    • Olesen, J.B.1    Torp-Pedersen, C.2    Hansen, M.L.3    Lip, G.Y.4
  • 8
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
    • (2001) JAMA , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3    Boechler, M.4    Rich, M.W.5    Radford, M.J.6
  • 9
    • 77957699729 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)
    • A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, and S. Ernst Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
    • (2010) Eur Heart J , vol.31 , pp. 2369-2429
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3    Schotten, U.4    Savelieva, I.5    Ernst, S.6
  • 10
    • 84856745317 scopus 로고    scopus 로고
    • Antithrombotic therapy for atrial fibrillation: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • J.J. You, D.E. Singer, P.A. Howard, D.A. Lane, M.H. Eckman, and M.C. Fang Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e531S e575S
    • (2012) Chest , vol.141
    • You, J.J.1    Singer, D.E.2    Howard, P.A.3    Lane, D.A.4    Eckman, M.H.5    Fang, M.C.6
  • 11
    • 84858595913 scopus 로고    scopus 로고
    • Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: Recommendations for stroke prevention and rate/rhythm control
    • A.C. Skanes, J.S. Healey, J.A. Cairns, P. Dorian, A.M. Gillis, and M.S. McMurtry Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control Can J Cardiol 28 2012 125 136
    • (2012) Can J Cardiol , vol.28 , pp. 125-136
    • Skanes, A.C.1    Healey, J.S.2    Cairns, J.A.3    Dorian, P.4    Gillis, A.M.5    McMurtry, M.S.6
  • 12
    • 33344461585 scopus 로고    scopus 로고
    • Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
    • B.F. Gage, Y. Yan, P.E. Milligan, A.D. Waterman, R. Culverhouse, and M.W. Rich Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF) Am Heart J 151 2006 713 719
    • (2006) Am Heart J , vol.151 , pp. 713-719
    • Gage, B.F.1    Yan, Y.2    Milligan, P.E.3    Waterman, A.D.4    Culverhouse, R.5    Rich, M.W.6
  • 13
    • 33751255101 scopus 로고    scopus 로고
    • Development of a contemporary bleeding risk model for elderly warfarin recipients
    • T.I. Shireman, J.D. Mahnken, P.A. Howard, T.F. Kresowik, Q. Hou, and E.F. Ellerbeck Development of a contemporary bleeding risk model for elderly warfarin recipients Chest 130 2006 1390 1396
    • (2006) Chest , vol.130 , pp. 1390-1396
    • Shireman, T.I.1    Mahnken, J.D.2    Howard, P.A.3    Kresowik, T.F.4    Hou, Q.5    Ellerbeck, E.F.6
  • 14
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
    • R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
    • (2010) Chest , vol.138 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3    De Vos, C.B.4    Crijns, H.J.5    Lip, G.Y.6
  • 15
    • 80052094564 scopus 로고    scopus 로고
    • A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study
    • M.C. Fang, A.S. Go, Y. Chang, L.H. Borowsky, N.K. Pomernacki, and N. Udaltsova A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study J Am Coll Cardiol 58 2011 395 401
    • (2011) J Am Coll Cardiol , vol.58 , pp. 395-401
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3    Borowsky, L.H.4    Pomernacki, N.K.5    Udaltsova, N.6
  • 16
    • 79955591110 scopus 로고    scopus 로고
    • Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study
    • A. Nobili, G. Licata, F. Salerno, L. Pasina, M. Tettamanti, and C. Franchi Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study Eur J Clin Pharmacol 67 2011 507 519
    • (2011) Eur J Clin Pharmacol , vol.67 , pp. 507-519
    • Nobili, A.1    Licata, G.2    Salerno, F.3    Pasina, L.4    Tettamanti, M.5    Franchi, C.6
  • 17
    • 78650878679 scopus 로고    scopus 로고
    • Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score
    • G.Y. Lip, L. Frison, J.L. Halperin, and D.A. Lane Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score J Am Coll Cardiol 57 2011 173 180
    • (2011) J Am Coll Cardiol , vol.57 , pp. 173-180
    • Lip, G.Y.1    Frison, L.2    Halperin, J.L.3    Lane, D.A.4
  • 18
    • 79959323975 scopus 로고    scopus 로고
    • Bleeding risk in 'real world' patients with atrial fibrillation: Comparison of two established bleeding prediction schemes in a nationwide cohort
    • J.B. Olesen, G.Y. Lip, P.R. Hansen, J. Lindhardsen, O. Ahlehoff, and C. Andersson Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort J Thromb Haemost 9 2011 1460 1467
    • (2011) J Thromb Haemost , vol.9 , pp. 1460-1467
    • Olesen, J.B.1    Lip, G.Y.2    Hansen, P.R.3    Lindhardsen, J.4    Ahlehoff, O.5    Andersson, C.6
  • 21
    • 0035944786 scopus 로고    scopus 로고
    • Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study
    • P.J. Devereaux, D.R. Anderson, M.J. Gardner, W. Putnam, G.J. Flowerdew, and B.F. Brownell Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study BMJ 323 2001 1218 1222
    • (2001) BMJ , vol.323 , pp. 1218-1222
    • Devereaux, P.J.1    Anderson, D.R.2    Gardner, M.J.3    Putnam, W.4    Flowerdew, G.J.5    Brownell, B.F.6
  • 22
    • 84866088694 scopus 로고    scopus 로고
    • A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
    • S.A. LaHaye, S.L. Gibbens, D.G. Ball, A.G. Day, J.B. Olesen, and A.C. Skanes A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation Eur Heart J 33 2012 2163 2171
    • (2012) Eur Heart J , vol.33 , pp. 2163-2171
    • Lahaye, S.A.1    Gibbens, S.L.2    Ball, D.G.3    Day, A.G.4    Olesen, J.B.5    Skanes, A.C.6
  • 23
    • 84873702791 scopus 로고    scopus 로고
    • Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: A Swedish study of prescribed drugs in primary care in 2002 and 2007
    • A.C. Carlsson, P. Wandell, K. Sundquist, S.E. Johansson, and J. Sundquist Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007 Eur J Clin Pharmacol 69 2013 245 253
    • (2013) Eur J Clin Pharmacol , vol.69 , pp. 245-253
    • Carlsson, A.C.1    Wandell, P.2    Sundquist, K.3    Johansson, S.E.4    Sundquist, J.5
  • 24
    • 82255192035 scopus 로고    scopus 로고
    • Risk stratification schemes, anticoagulation use and outcomes: The risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation
    • R. Sandhu, A.B. Bakal, J.A. Ezekowitz, and F.A. McAlister Risk stratification schemes, anticoagulation use and outcomes: the risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation Heart 97 2011 2046 2050
    • (2011) Heart , vol.97 , pp. 2046-2050
    • Sandhu, R.1    Bakal, A.B.2    Ezekowitz, J.A.3    McAlister, F.A.4
  • 25
    • 33947413877 scopus 로고    scopus 로고
    • A randomised controlled trial of warfarin versus aspirin for stroke prevention on octogenarians with AF (WASPO)
    • A. Rash, T. Downes, R. Portner, W.W. Yeo, N. Morgan, and K.S. Channer A randomised controlled trial of warfarin versus aspirin for stroke prevention on octogenarians with AF (WASPO) Age Ageing 36 2007 151 156
    • (2007) Age Ageing , vol.36 , pp. 151-156
    • Rash, A.1    Downes, T.2    Portner, R.3    Yeo, W.W.4    Morgan, N.5    Channer, K.S.6
  • 26
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with AF (the Birmingham AF Treatment of the Aged Study BAFTA): A randomised controlled trial
    • J. Mant, R. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, and G.Y. Lip Warfarin versus aspirin for stroke prevention in an elderly community population with AF (the Birmingham AF Treatment of the Aged Study BAFTA): a randomised controlled trial Lancet 370 2007 493 503
    • (2007) Lancet , vol.370 , pp. 493-503
    • Mant, J.1    Hobbs, R.2    Fletcher, K.3    Roalfe, A.4    Fitzmaurice, D.5    Lip, G.Y.6
  • 27
    • 84877742568 scopus 로고    scopus 로고
    • The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure
    • Y. Guo, G.Y. Lip, and S. Apostolakis The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure J Cardiovasc Transl Res 6 2013 388 397
    • (2013) J Cardiovasc Transl Res , vol.6 , pp. 388-397
    • Guo, Y.1    Lip, G.Y.2    Apostolakis, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.